Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypothermia and Magnesium Sulfate in Severe TBI
NCT01333488Phase 2Terminated
- Sponsor
- United States Department of Defense
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium sulfate in traumatic brain injury (TBI), sponsored by United States Department of Defense. Started Dec 2011; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01333488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333488.